LENZ · CIK 0001815776 · operating
LENZ Therapeutics, Inc. (LENZ) is a biological products, (no diagnostic substances) company incorporated in DE, listed on the Nasdaq. With a market capitalization of $422 million, LENZ Therapeutics, Inc. is a small-cap company. The stock currently trades at $13.69, up 1.45% today, with a 52-week range of $11.48–$50.40.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-2.34 | $-2.34 | -6.8% | |
| 2023 | $-2.19 | $-2.19 | -19.0% | |
| 2022 | $-1.84 | $-1.84 | — | |
| 2021 | — | — | — |